Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes

NCT07321067 is registered in ClinicalTrials.gov with Ahmed Karam Helmy as lead sponsor.

NCT NCT07321067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07321067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
Lead sponsor
Ahmed Karam Helmy
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
November 1, 2027
Enrollment
75 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma (hcc)